[#item_full_content] InterCure to acquire ISHI in two-phase deal for 4.9M shares, gaining access to U.S. cannabis genetics and The Flowery partnership. Deal closes Q1 2026, subject to regulatory approval. Read More

[#item_full_content] InterCure to acquire ISHI in two-phase deal for 4.9M shares, gaining access to U.S. cannabis genetics and The Flowery partnership. Deal closes Q1 2026, subject to regulatory approval. Read More